Tech Company Financing Transactions

Lymphatica Medtech Funding Round

On 10/9/2024, Lymphatica Medtech announced $19.5 million in Series B funding from CDP Venture Capital, Panakes Partners and TechWald Holding.

Transaction Overview

Company Name
Announced On
10/9/2024
Transaction Type
Venture Equity
Amount
$19,500,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to accelerate the clinical development and validation of LymphoDrain, an implantable device designed to treat lymphedema, a chronic vascular condition that currently has no cure and affects millions worldwide.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
EPFL Innovation Park Bâtiment E
Lausanne, 1015
Switzerland
Phone
Undisclosed
Email Address
Overview
We are a spin-off company out of the Angiology Division of the Lausanne University Hospital (CHUV) and of the Laboratory of Lymphatic and Cancer Bioengineering of the Swiss Federal Institute of Technology in Lausanne (EPFL). Lymphatica Medtech was founded in 2017 by Dr. Triacca and Dr. Pisano, and it is based in Ecublens (Vaud), on the shores of Lake Geneva, in the EPFL Innovation Park Campus.
Profile
Lymphatica Medtech LinkedIn Company Profile
Social Media
Lymphatica Medtech Company Twitter Account
Company News
Lymphatica Medtech News
Facebook
Lymphatica Medtech on Facebook
YouTube
Lymphatica Medtech on YouTube

Management Team

Title
Name
Email & Social
Chairman
Dan Rose
  Dan Rose LinkedIn Profile  Dan Rose Twitter Account  Dan Rose News  Dan Rose on Facebook
Chief Executive Officer
Marco Pisano
  Marco Pisano LinkedIn Profile  Marco Pisano Twitter Account  Marco Pisano News  Marco Pisano on Facebook
Chief Operating Officer
Valentina Triacca
  Valentina Triacca LinkedIn Profile  Valentina Triacca Twitter Account  Valentina Triacca News  Valentina Triacca on Facebook
VP - R & D
Mathieu Aberle
  Mathieu Aberle LinkedIn Profile  Mathieu Aberle Twitter Account  Mathieu Aberle News  Mathieu Aberle on Facebook
VP - Regulatory Affairs
Vicky Boucard
  Vicky Boucard LinkedIn Profile  Vicky Boucard Twitter Account  Vicky Boucard News  Vicky Boucard on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/9/2024: Human Security venture capital transaction
Next: 10/9/2024: APRO Oracle venture capital transaction

 

Share this article

 


News on VC Transactions

We report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary